Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Placenta previa (PP) is an obstetric condition that is closely linked with massive obstetric hemorrhage with a varied incidence about once in every 150-250 live births. Insertion of intrauterine balloon tamponade has been suggested in the management of massive postpartum hemorrhage (PPH). The Bakri balloon has a sausage-like spindle shape and a drainage lumen and is made of silicon. It has been used in cases of uterine atony and placenta previa with a success rate of 90%. However, Bakri balloon is not available in all countries.
The aim of this study is to evaluate the efficacy of the use of intrauterine inflated Foley's catheter balloon with or without intravenous tranexamic acid to control PPH during cesarean delivery in cases of placenta previa.
Eligible participants were allocated to one of two groups. Group (I): patients managed by Intrauterine Inflated Foley's Catheter Balloon after delivery of the fetus. Group (II): patients received 1 gm tranexamic acid (TA), (2 ampoules of Capron® 500 mg /5 ml; Cairo, Egypt) intravenous just before skin incision plus Intrauterine Inflated Foley's Catheter Balloon. In group I, patients received a single injection of intravenous saline before skin incision prepared in a syringe and coded by a pharmacist in the pharmacy of the hospital. Neither the surgeon nor the anesthetist will know the nature of the IV administered drug before cesarean section.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Foley's Catheter plus TA | Active Comparator | patients managed by Intrauterine Inflated Foley's Catheter Balloon after delivery of the fetus plus 1 gm tranexamic acid in 100ml saline intravenous just before skin incision |
|
| Foley's Catheter plus placebo to TA | Active Comparator | patients managed by Intrauterine Inflated Foley's Catheter Balloon after delivery of the fetus plus single injection of 100 ml intravenous saline before skin incision |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Foley's Catheter | Procedure | patients managed by Intrauterine Inflated Foley's Catheter Balloon after delivery of the fetus. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants with postpartum hemorrhage | number of participant with blood loss > 1000ml | 24 hours post operative |
| Measure | Description | Time Frame |
|---|---|---|
| intraoperative blood loss | amount of blood loss during cesarean section | during the operation |
| The number of participant needed for blood transfusion | Calculation of the number of participant needed for blood transfusion |
Not provided
Inclusion Criteria:
Exclusion Criteria:
All pregnant women with a single term fetus scheduled for an elective cesarean section for complete placenta previa
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| hany f sallam, md | Contact | 01022336052 | hany.farouk@aswu.edu.eg |
| Name | Affiliation | Role |
|---|---|---|
| hany f sallam, md | Aswan University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aswan University | Recruiting | Aswān | 81528 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010923 | Placenta Previa |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
The study was a double-blind randomized controlled trial carried out in a tertiary University Hospital
Not provided
Not provided
The trial will be appropriately blinded; the participants, outcome assessors and the surgeon performing the procedure will be blinded to the medication type, which was used.
|
| TA | Drug | patients received 1 gm tranexamic acid intravenous just before skin incision in 100 ml saline |
|
|
| Placebo | Drug | patients received 100 ml saline just before skin incision |
|
|
| 24 hours postoperative |
| number of participant need of extra surgical maneuvers | number of participant need of extra surgical maneuvers like internal iliac ligation or hysterectomy | 24 hours post operative |
| D010922 | Placenta Diseases |